| Revision as of 10:34, 17 November 2010 editLoveless (talk | contribs)4,407 editsm robot Adding: ja:トスフロキサシン← Previous edit | Revision as of 01:15, 21 January 2011 edit undoPashihiko (talk | contribs)Extended confirmed users3,559 editsNo edit summaryNext edit → | ||
| Line 7: | Line 7: | ||
| | PubChem = 5517 | | PubChem = 5517 | ||
| | DrugBank = | | DrugBank = | ||
| | KEGG = D02317 | |||
| | C=19|H=15|F=3|N=4|O=3 | | C=19|H=15|F=3|N=4|O=3 | ||
| | molecular_weight = 404.34 g/mol | | molecular_weight = 404.34 g/mol | ||
Revision as of 01:15, 21 January 2011
Pharmaceutical compound | |
| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| KEGG | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C19H15F3N4O3 |
| Molar mass | 404.34 g/mol g·mol |
Tosufloxacin is a fluoroquinolone antibiotic. It has a controversial safety profile in relation to other fluoroquinolones. It is associated with severe thrombocytopenia and nephritis, and hepatotoxicity. It is sold in Japan under the brand name Ozex.
See also
References
- Rubinstein, E. (2001). "History of quinolones and their side effects". Chemotherapy. 47 Suppl 3: 3–8, discussion 44–8. PMID 11549783.
{{cite journal}}: Cite has empty unknown parameter:|month=(help)
| Antibacterials that inhibit nucleic acid (J01E, J01M) | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Antifolates (inhibit bacterial purine metabolism, thereby inhibiting DNA and RNA synthesis) |
| ||||||||||||||||
| Quinolones (inhibit bacterial topoisomerase and/or DNA gyrase, thereby inhibiting DNA replication) |
| ||||||||||||||||
| Anaerobic DNA inhibitors |
| ||||||||||||||||
| RNA synthesis |
| ||||||||||||||||
| |||||||||||||||||
 | This systemic antibiotic-related article is a stub. You can help Misplaced Pages by expanding it. |